I’ve been directly involved with Dana-Farber as a Governing Trustee since 2014 and have chaired the Trustee Science Committee since 2017. I became involved because, as a healthcare investor who follows the development of cutting-edge oncology medicines closely, I see supporting Dana-Farber as a way to make significant progress toward a cure for cancer. Cancer has impacted us all directly and indirectly and pound-for-pound, person-for-person and dollar-for-dollar there is no other cancer research institute that has made as much progress toward a cancer cure as Dana-Farber. I see the incremental impact of Dana-Farber’s research at all of the national cancer research meetings I attend and every time I meet the dedicated researchers at the Institute. Simply put, my goal is to help lead the effort to provide more resources to dramatically accelerate this scientific progress so Dana-Farber’s unequaled team of clinicians and scientists can end cancer.